• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在服用利尿剂的老年患者中,非甾体抗炎药会增加充血性心力衰竭的风险。

NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics.

作者信息

Heerdink E R, Leufkens H G, Herings R M, Ottervanger J P, Stricker B H, Bakker A

机构信息

Department of Pharmacoepidemiology and Pharmacotherapy, University of Utrecht, The Netherlands.

出版信息

Arch Intern Med. 1998 May 25;158(10):1108-12. doi: 10.1001/archinte.158.10.1108.

DOI:10.1001/archinte.158.10.1108
PMID:9605782
Abstract

BACKGROUND

Both diuretics and nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used, in particular among the elderly. The use of NSAIDs may decrease the efficacy of diuretics and induce congestive heart failure (CHF) in patients treated with diuretics.

OBJECTIVE

To investigate the risk of CHF associated with combined use of diuretics and NSAIDs in patients older than 55 years.

METHODS

We conducted a study in a base cohort of 10,519 recipients of diuretics and NSAIDs identified in the PHARMO database during the period from 1986 through 1992. The incidence density of hospitalizations for CHF during exposure to both diuretics and NSAIDs (index) was compared with that during exposure to diuretics only (reference).

RESULTS

We found an overall increased risk of hospitalization for CHF during periods of concomitant use of diuretics and NSAIDs compared with use of diuretics only (crude relative risk, 2.2; 95% confidence interval, 1.7-2.9). After adjusting for cofactors including age, sex, history of hospitalization, and drug use, a 2-fold increased risk remained (relative risk, 1.8; 95% confidence interval, 1.4-2.4).

CONCLUSION

Use of NSAIDs in elderly patients taking diuretics is associated with a 2-fold increased risk of hospitalization for CHF, especially in those with existing serious CHF.

摘要

背景

利尿剂和非甾体抗炎药(NSAIDs)均被广泛使用,尤其是在老年人中。NSAIDs的使用可能会降低利尿剂的疗效,并在接受利尿剂治疗的患者中诱发充血性心力衰竭(CHF)。

目的

调查55岁以上患者联合使用利尿剂和NSAIDs与CHF相关的风险。

方法

我们在1986年至1992年期间从PHARMO数据库中确定的10519名接受利尿剂和NSAIDs治疗的患者的基础队列中进行了一项研究。将同时暴露于利尿剂和NSAIDs(指数)期间CHF住院的发病密度与仅暴露于利尿剂期间(对照)进行比较。

结果

我们发现,与仅使用利尿剂相比,同时使用利尿剂和NSAIDs期间CHF住院的总体风险增加(粗相对风险,2.2;95%置信区间,1.7-2.9)。在对包括年龄、性别、住院史和药物使用等协变量进行调整后,风险仍增加了2倍(相对风险,1.8;95%置信区间,1.4-2.4)。

结论

在服用利尿剂的老年患者中使用NSAIDs与CHF住院风险增加2倍相关,尤其是在已有严重CHF的患者中。

相似文献

1
NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics.在服用利尿剂的老年患者中,非甾体抗炎药会增加充血性心力衰竭的风险。
Arch Intern Med. 1998 May 25;158(10):1108-12. doi: 10.1001/archinte.158.10.1108.
2
Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem.非甾体抗炎药的使用与老年患者充血性心力衰竭的发生:一个未得到充分认识的公共卫生问题。
Arch Intern Med. 2000 Mar 27;160(6):777-84. doi: 10.1001/archinte.160.6.777.
3
Selective COX-2 inhibitors, NSAIDs and congestive heart failure: differences between new and recurrent cases.选择性环氧化酶-2抑制剂、非甾体抗炎药与充血性心力衰竭:新发病例与复发病例的差异
Br J Clin Pharmacol. 2008 Jun;65(6):927-34. doi: 10.1111/j.1365-2125.2008.03121.x. Epub 2008 Apr 1.
4
Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population.非甾体抗炎药与普通人群急性肾衰竭的风险
Am J Kidney Dis. 2005 Mar;45(3):531-9. doi: 10.1053/j.ajkd.2004.12.005.
5
Nonsteroidal Anti-Inflammatory Drugs and Risk of First Hospitalization for Heart Failure in Patients with No History of Heart Failure: A Population-Based Case-Crossover Study.非甾体抗炎药与无心力衰竭史患者首次心力衰竭住院风险的相关性:基于人群的病例交叉研究。
Drug Saf. 2019 Jan;42(1):67-75. doi: 10.1007/s40264-018-0720-9.
6
Adverse cardiovascular effects of NSAIDs in patients with congestive heart failure.非甾体抗炎药对充血性心力衰竭患者的不良心血管影响。
Drug Saf. 1997 Sep;17(3):166-80. doi: 10.2165/00002018-199717030-00003.
7
Association of nonsteroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure: the Rotterdam Study.非甾体抗炎药与首次发生心力衰竭及复发性心力衰竭的关联:鹿特丹研究
Arch Intern Med. 2002 Feb 11;162(3):265-70. doi: 10.1001/archinte.162.3.265.
8
Retrospective cohort study of association of NSAIDS exposure and outcome of acute decompensated congestive heart failure.非甾体抗炎药暴露与急性失代偿性充血性心力衰竭结局关联的回顾性队列研究。
J Med Assoc Thai. 2013 Apr;96(4):423-31.
9
Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study.环氧化酶-2抑制剂与非选择性非甾体抗炎药及老年患者充血性心力衰竭结局:一项基于人群的队列研究
Lancet. 2004 May 29;363(9423):1751-6. doi: 10.1016/S0140-6736(04)16299-5.
10
Risk of congestive heart failure with nonsteroidal antiinflammatory drugs and selective Cyclooxygenase 2 inhibitors: a class effect?非甾体抗炎药和选择性环氧化酶-2抑制剂与充血性心力衰竭风险:是否为类效应?
Arthritis Rheum. 2007 Apr 15;57(3):516-23. doi: 10.1002/art.22614.

引用本文的文献

1
Palliative Care and Hospice for Heart Failure Patients: Position Statement From the Korean Society of Heart Failure.心力衰竭患者的姑息治疗与临终关怀:韩国心力衰竭学会立场声明
Int J Heart Fail. 2025 Jan 15;7(1):32-46. doi: 10.36628/ijhf.2024.0069. eCollection 2025 Jan.
2
Combination diuretic therapies in heart failure: Insights from GUIDE-IT.心力衰竭中的联合利尿剂治疗:来自GUIDE-IT的见解。
Am Heart J Plus. 2024 Jul 30;45:100436. doi: 10.1016/j.ahjo.2024.100436. eCollection 2024 Sep.
3
Diuretic Treatment in Heart Failure: A Practical Guide for Clinicians.
心力衰竭的利尿治疗:临床医生实用指南
J Clin Med. 2024 Jul 30;13(15):4470. doi: 10.3390/jcm13154470.
4
Vulnerable period in heart failure: a window of opportunity for the optimization of treatment - a statement by Mexican experts.心力衰竭的易损期:优化治疗的机遇之窗——墨西哥专家声明
Drugs Context. 2024 Jan 16;13. doi: 10.7573/dic.2023-8-1. eCollection 2024.
5
Antioxidant Effects of Catechins (EGCG), Andrographolide, and Curcuminoids Compounds for Skin Protection, Cosmetics, and Dermatological Uses: An Update.儿茶素(表没食子儿茶素没食子酸酯)、穿心莲内酯和姜黄素类化合物在皮肤保护、化妆品及皮肤科应用中的抗氧化作用:最新进展
Antioxidants (Basel). 2023 Jun 21;12(7):1317. doi: 10.3390/antiox12071317.
6
Comparative effectiveness of generic commercial versus locally customized clinical decision support tools to reduce prescription of nonsteroidal anti-inflammatory drugs for patients with heart failure.比较通用商业版和本地定制版临床决策支持工具在减少心力衰竭患者非甾体抗炎药处方方面的效果。
J Am Med Inform Assoc. 2023 Aug 18;30(9):1516-1525. doi: 10.1093/jamia/ocad109.
7
Time until onset of acute kidney injury by combination therapy with "Triple Whammy" drugs obtained from Japanese Adverse Drug Event Report database.从日本药物不良反应报告数据库获得的“三重奏”药物联合治疗急性肾损伤的起始时间。
PLoS One. 2022 Feb 9;17(2):e0263682. doi: 10.1371/journal.pone.0263682. eCollection 2022.
8
Palliative Care for People Living With Heart Disease-Does Sex Make a Difference?心脏病患者的姑息治疗——性别有影响吗?
Front Cardiovasc Med. 2021 Feb 5;8:629752. doi: 10.3389/fcvm.2021.629752. eCollection 2021.
9
Validity of Acute Cardiovascular Outcome Diagnoses Recorded in European Electronic Health Records: A Systematic Review.欧洲电子健康记录中记录的急性心血管疾病诊断结果的有效性:一项系统综述。
Clin Epidemiol. 2020 Oct 14;12:1095-1111. doi: 10.2147/CLEP.S265619. eCollection 2020.
10
Pathophysiological mechanisms underlying a rat model of triple whammy acute kidney injury.三重打击急性肾损伤大鼠模型的病理生理机制。
Lab Invest. 2020 Nov;100(11):1455-1464. doi: 10.1038/s41374-020-0473-9. Epub 2020 Jul 27.